Phase II trial of pegylated-liposomal doxorubicin in the treatment of locally advanced unresectable or metastatic transitional cell carcinoma of the urothelial tract

By Winquist E.   Ernst D.S.   Jonker D.   Moore M.J.   Segal R.   Lockwood G.   Rodgers A.  

European Journal of Cancer, Vol. 39, Iss. 13, 2003-09 ,pp. : 1866-1871

Elsevier

Access to resources Recommend Favorite

A phase II study of DaunoXome ( R) in advanced urothelial transitional cell carcinoma

By Fossa S.D.   Aass N.   Paro G.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1131-1132

Elsevier

Access to resources Recommend Favorite

Phase II trial of interleukin 2, interferon , and 5-fluorouracil in metastatic renal cell cancer - a cytokine working group study.

By Dutcher J.   Logan T.   Gordon M.   Sosman J.   Weiss G.   Margolin K.   Plasse T.   Mier J.   Lotze M.   Clark J.   Atkins M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 2, 2002-03 ,pp. : 83-84

Elsevier

Access to resources Recommend Favorite

A Phase II Study of Dacarbazine, Cisplatin, Interferon- and High-dose Interleukin-2 in 'Poor-risk' Metastatic Melanoma

By Proebstle T.M.   Scheibenbogen C.   Sterry W.   Keilholz U.  

European Journal of Cancer, Vol. 32, Iss. 9, 1996-08 ,pp. : 1530-1533

Elsevier

Access to resources Recommend Favorite

Phase II study of interleukin-2 and 13-cis-retinoic acid as maintenance therapy in metastatic colorectal cancer

By Recchia Francesco   Saggio Gaetano   Cesta Alisia   Candeloro Giampiero   Blasio Anna   Amiconi Giovanna   Lombardo Marco   Nuzzo Antonio   Lalli Angelo   Alesse Edoardo   Necozione Stefano   Rea Silvio  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 5, 2007-05 ,pp. : 699-708

Springer Publishing Company

Access to resources Recommend Favorite